直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

PTAB Statistics for Final Written Decisions Issued in July and August 2024

October 8, 2024

Authored and Edited by Daniel F. Klodowski; Umber Aggarwal; A. Sasha Hoyt; Deena Kablaoui Lanier; Elliot C. Cook

In July, a relatively difficult month for patent owners, the PTAB cancelled 582 (89.40%) instituted claims across 20 IPR and PGR Final Written Decisions, including decisions issued following remand from the Federal Circuit.  After review, 63 (9.68%) instituted claims survived, and patent owners conceded 6 (0.92%) instituted claims through motions to amend or disclaimer.  For comparison, the cumulative average cancellation rate of instituted claims in IPR, CBM, and PGR Final Written Decisions is about 73%.

On a per-case basis, no instituted or substitute claims survived in 39 (81.25%) decisions, all instituted claims survived in 3 (6.25%) decision, and a mixed outcome occurred in 6 (12.5%) decisions.  A mixed outcome occurs where at least one instituted or substitute claim remains patentable, and at least one is cancelled, in a Final Written Decision. 

In August, a relatively favorable month for patent owners, the PTAB cancelled 261 (67.44%) instituted claims across 23 IPR and PGR Final Written Decisions. In those decisions, 126 (32.56%) instituted claims survived, and patent owners did not concede any instituted claims through motions to amend or disclaimer. 

On a per-case basis, no instituted or substitute claims survived in 12 (52.17%) decisions, all instituted claims survived in 7 (30.43%) decisions, and a mixed outcome occurred in 4 (17.39%) decisions in August.  

Through August 31, 2024, the PTAB has cumulatively granted 662 (15.90%) proposed substitute claims in motions to amend in IPRs, while denying 3,501 (84.10%) proposed substitute claims. 

The overall cumulative instituted claim survival rate in IPRs, CBMs, and PGRs through August 31, 2024, broken down by technology center, is as follows:

The cumulative number of Final Written Decisions through August 31, 2024, separated by technology center, is as follows:

Additional cumulative statistics on the Board’s IPR, CBM, and PGR decisions, updated through August 31, 2024, are available here on the At the PTAB blog. 

Related Practices

Appeals, Issues, and Legal Strategy

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Offices

Reston, VA

Washington, DC

Contacts

Daniel F. Klodowski
Partner
Washington, DC
+1 202 408 4216
Email
Umber Aggarwal
Associate
Reston, VA
+1 571 203 2423
Email
A. Sasha Hoyt
Associate
Washington, DC
+1 202 408 4230
Email
Deena Kablaoui Lanier
Associate
Washington, DC
+1 202 408 4115
Email
Elliot C. Cook
Partner
Reston, VA
+1 571 203 2738
Email

Copyright © 2024 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Hybrid Conference

Intellectual Property Law Institute 2026 – California

October 19-20, 2026

San Francisco

Hybrid Conference

Intellectual Property Law Institute 2026 – New York

September 28-29, 2026

New York

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Webinar

U.S. Patent Case Law Update 2026

July 23, 2026

Webinar

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

Webinar

Webinar

Early Motions in Trade Secret Litigation – Offensive and Defensive Insights

July 15, 2026

Webinar

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP